Encainide for treatment of supraventricular tachycardias associated with the Wolff-Parkinson-White syndrome
- 29 August 1986
- journal article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 58 (5) , C41-C48
- https://doi.org/10.1016/0002-9149(86)90103-7
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Clinical efficacy and electrophysiologic effects of intravenous and oral encainide in patients with accessory atrioventricular pathways and supraventricular arrhythmiasThe American Journal of Cardiology, 1984
- Electrophysiologic and clinical effects of intravenous and oral encainide in accessory atrioventricular pathwayThe American Journal of Cardiology, 1984
- Clinical efficacy and electrophysiologic effects of encainide in patients with Wolff-Parkinson-White syndrome.Circulation, 1984
- Electrophysiologic actions of O-demethyl encainide: an active metabolite.Circulation, 1983
- Electrophysiology of oral encainideThe American Journal of Cardiology, 1982
- Encainide: A new and potent antiarrhythmic agentAmerican Heart Journal, 1980
- Effect of drugs in the wolff-parkinson-white syndromeThe American Journal of Cardiology, 1980
- Clinical electrophysiologic effects of encainide, a newly developed antiarrhythmic agentThe American Journal of Cardiology, 1979